(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride
| 中文名称 | (R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride |
|---|---|
| 中文同义词 | 噻吩并[3,2-C]吡啶-5(4H)-乙酸,Α-(2-氯苯基)-6,7-二氢-甲酯,盐酸盐(1:1);2-(2-氯苯基)-2-(6,7-二氢噻吩并[3,2-c]吡啶-5(4H)-基)乙酸甲酯盐酸盐;(±)盐酸盐 |
| 英文名称 | (R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride |
| 英文同义词 | METHYL 2-(2-CHLOROPHENYL)-2-(4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDIN-5-YL)ACETATE HYDROCHLORIDE;(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetateHCl;(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride;(+/-)-Clopidogrelhydrochloride;(+/-)-Clopidogrel hydrochloride DISCONTINUED;Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate hydrochloride |
| CAS号 | 130209-90-4 |
| 分子式 | C16H17Cl2NO2S |
| 分子量 | 358.28 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 130209-90-4.mol |
| 结构式 | ![(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride 结构式](CAS/20180906/GIF/130209-90-4.gif) |
(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride 性质
| 储存条件 | Store at -20°C |
|---|---|
| 溶解度 | DMF：20mg/mL； DMSO：20mg/mL； DMSO:PBS(pH 7.2)(1:2)：0.33 mg/ml；乙醇：5mg/mL |
| 形态 | 结晶固体 |
(R,S)-Methyl-2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothino[3.2-c]pyridin-5-yl)acetatehydrochloride 用途与合成方法
(±)-Clopidogrel hydrochloride 是抗血栓剂，具有 ADP 选择性和口服有效性。(±)-Clopidogrel hydrochloride 通过抑制 ADP 与其血小板受体的结合，而抑制血小板聚集。